ÇѸ²´ëÇб³¼º½Éº´¿ø

½É¸í¼± ±³¼ö

031-380-3850
  • Àü¹®¼¾ÅÍ ·Îº¿¼ö¼ú¼¾ÅÍ
  • Áø·á°ú ºñ´¢ÀÇÇаú

Àü¹®Áø·áºÐ¾ß

ºñ´¢±â Á¾¾ç, ´ÙºóÄ¡·Îº¿¼ö¼ú, º¹°­°æ¼ö¼ú, Àü¸³¼±, ¼Ò¾Æ ºñ´¢±â Áúȯ

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2022-08-15 ~ 2022-08-20)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

ÇѾç´ëÇб³ Àǰú´ëÇÐ Á¹¾÷

¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¼®»ç

¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¹Ú»ç

°æ·Â

°æ·Â

Çö) ÇѸ²´ëÇб³¼º½Éº´¿ø ºñ´¢ÀÇÇаú ºÎ±³¼ö

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ ÈÄ¿ø ÇØ¿Ü ´ÙºóÄ¡ ·Îº¿ ¿¬¼ö, Stanford Hospital, Stanford, CA, USA

ÇѸ²´ëÇб³¼º½Éº´¿ø ºñ´¢ÀÇÇаú Á¶±³¼ö

¼­¿ï¾Æ»êº´¿ø ºñ´¢ÀÇÇаú ÀÓ»ó°­»ç

¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ ¹× Àü°øÀÇ, Àü¹®ÀÇ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇѺñ´¢±â°úÇÐȸ Á¤È¸¿ø

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ Á¤È¸¿ø

´ëÇѳ»ºñ´¢±âÇÐȸ Á¤È¸¿ø

´ëÇѺñ´¢±â°úÇÐȸ(American Urology Association) Á¤È¸¿ø

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ ºÎÃѹ«

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ ÇмúÀ§¿øÈ¸ À§¿ø

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ ±¹Á¦±³·ùÃßÁøÀ§¿øÈ¸ À§¿ø

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ Àü¸³¼±¾ÏÁø·á±Ç°í¾ÈƯº°À§¿øÈ¸ À§¿ø

´ëÇѺñ´¢±â°úÇÐȸÁö ÆíÁýÀ§¿ø (Investigative and Clinical Urology, Production editor)

´ëÇѼҾƺñ´¢±â°úÇÐȸ Á¤È¸¿ø

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

´ëÇÑ Endourology ÇÐȸ Best presentation award (2014)

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ ÀåÇлý (2014)

¼­¿ï¾Æ»êº´¿ø ǥâÀå (2013)

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ °ø¸ð³í¹® ´ë»ó (2013)

³í¹®

Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial (Investigative and Clinical Urology)

The association between family history of prostate cancer and development of prostate cancer among Korean population: A prospective cohort study using KoGES data (Medicine)

Risk of dementia and Parkinson¢¥s disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study (PLoS One)

Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study (Investigative and Clinical Urology)

The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study. (Journal of Korean Medical Science)

Taxane-based Chemotherapy Induced Androgen Receptor Splice Variant 7 in Patients with Castration-Resistant Prostate Cancer: A Tissue-based Analysis (Scientific Reports)

Taxane-based Chemotherapy Induced Androgen Receptor Splice Variant 7 in Patients with Castration-Resistant Prostate Cancer: A Tissue-based Analysis. (Scientific Reports)

Correlation between prostatic urethral angulation and symptomatic improvement after surgery in patients with lower urinary tract symptoms according to prostate size. (World J Urol)

Integrity of the Urethral Sphincter Complex, Nerve-sparing, and Long-term Continence Status after Robotic-assisted Radical Prostatectomy. (European Urology Focus)

Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide. (Investig Clin Urol)